BACKGROUND: It has previously been reported that patients infected with Burkholderia cenocepacia (genomovar III) before lung transplantation have a poorer outcome than those with other B. cepacia complex infections. METHODS: An extensive study was conducted to determine the prevalence and clonality of B. cepacia complex genomovars isolated from patients referred for transplant assessment between 1989 to the present and, where appropriate, whether strain type was related to transplant outcome. RESULTS: Isolates from 29 patients were identified as B. cepacia complex organisms by molecular analysis. Thirteen patients (45%) were infected with the highly transmissible ET-12 strain of B. cenocepacia recA lineage III-A, while all remaining patients were infected with genetically unique B. cenocepacia, B. multivorans, and B. vietnamiensis strains. All previously reported deaths following transplantation were associated with ET-12 infection. CONCLUSIONS: The ET-12 strain is the predominant cause of B. cenocepacia infections in patients with cystic fibrosis referred to our pulmonary transplant centre and is associated with poor transplant outcomes using standard treatment regimens.
BACKGROUND: It has previously been reported that patients infected with Burkholderia cenocepacia (genomovar III) before lung transplantation have a poorer outcome than those with other B. cepacia complex infections. METHODS: An extensive study was conducted to determine the prevalence and clonality of B. cepacia complex genomovars isolated from patients referred for transplant assessment between 1989 to the present and, where appropriate, whether strain type was related to transplant outcome. RESULTS: Isolates from 29 patients were identified as B. cepacia complex organisms by molecular analysis. Thirteen patients (45%) were infected with the highly transmissible ET-12 strain of B. cenocepacia recA lineage III-A, while all remaining patients were infected with genetically unique B. cenocepacia, B. multivorans, and B. vietnamiensis strains. All previously reported deaths following transplantation were associated with ET-12 infection. CONCLUSIONS: The ET-12 strain is the predominant cause of B. cenocepacia infections in patients with cystic fibrosis referred to our pulmonary transplant centre and is associated with poor transplant outcomes using standard treatment regimens.
Authors: A De Soyza; A McDowell; L Archer; J H Dark; S J Elborn; E Mahenthiralingam; K Gould; P A Corris Journal: Lancet Date: 2001-11-24 Impact factor: 79.321
Authors: A Agodi; M Barchitta; V Gianninò; A Collura; T Pensabene; M L Garlaschi; C Pasquarella; F Luzzaro; F Sinatra; E Mahenthiralingam; S Stefani Journal: J Hosp Infect Date: 2002-03 Impact factor: 3.926
Authors: C Chaparro; J Maurer; C Gutierrez; M Krajden; C Chan; T Winton; S Keshavjee; M Scavuzzo; E Tullis; M Hutcheon; S Kesten Journal: Am J Respir Crit Care Med Date: 2001-01 Impact factor: 21.405
Authors: E Mahenthiralingam; J Bischof; S K Byrne; C Radomski; J E Davies; Y Av-Gay; P Vandamme Journal: J Clin Microbiol Date: 2000-09 Impact factor: 5.948
Authors: David G Heath; Kathy Hohneker; Charlene Carriker; Kelly Smith; Jonathan Routh; John J LiPuma; Robert M Aris; David Weber; Peter H Gilligan Journal: J Clin Microbiol Date: 2002-04 Impact factor: 5.948
Authors: Peter Vandamme; Barry Holmes; Tom Coenye; Johan Goris; Eshwar Mahenthiralingam; John J LiPuma; John R W Govan Journal: Res Microbiol Date: 2003-03 Impact factor: 3.992
Authors: S Campana; G Taccetti; N Ravenni; F Favari; L Cariani; A Sciacca; D Savoia; A Collura; E Fiscarelli; G De Intinis; M Busetti; A Cipolloni; A d'Aprile; E Provenzano; I Collebrusco; P Frontini; G Stassi; M Trancassini; D Tovagliari; A Lavitola; C J Doherty; T Coenye; J R W Govan; P Vandamme Journal: J Clin Microbiol Date: 2005-10 Impact factor: 5.948
Authors: Anna Hanuszkiewicz; Paula Pittock; Fiachra Humphries; Hermann Moll; Amanda Roa Rosales; Antonio Molinaro; Paul N Moynagh; Gilles A Lajoie; Miguel A Valvano Journal: J Biol Chem Date: 2014-05-19 Impact factor: 5.157
Authors: Anthony De Soyza; Amanda J Hall; Eshwar Mahenthiralingam; Pavel Drevinek; Wieslaw Kaca; Zuzanna Drulis-Kawa; Stoyanka R Stoitsova; Veronika Toth; Tom Coenye; James E A Zlosnik; Jane L Burns; Isabel Sá-Correia; Daniel De Vos; Jean-Paul Pirnay; Timothy J Kidd; David Reid; Jim Manos; Jens Klockgether; Lutz Wiehlmann; Burkhard Tümmler; Siobhán McClean; Craig Winstanley Journal: Microbiologyopen Date: 2013-11-11 Impact factor: 3.139
Authors: Heleen Van Acker; Andrea Sass; Silvia Bazzini; Karen De Roy; Claudia Udine; Thomas Messiaen; Giovanna Riccardi; Nico Boon; Hans J Nelis; Eshwar Mahenthiralingam; Tom Coenye Journal: PLoS One Date: 2013-03-13 Impact factor: 3.240